Last 12 months
Inside the activity.
0 purchase rows · 54 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 10 |
| Jan 2026 | 0 | 3 |
| Feb 2026 | 0 | 3 |
| Mar 2026 | 0 | 4 |
| Apr 2026 | 0 | 5 |
| May 2026 | 0 | 12 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 4 |
| Aug 2026 | 0 | 6 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 03, 2021 Filed Aug 3, 2021 23:39 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
GiftCommon Stock | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-011090 · doc4.xml · nonDerivative · entry 2 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,551.82 Read SEC document |
| August 03, 2021 Filed Aug 3, 2021 23:39 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
Exercise / conversionCommon Stock | 45,050 | $21.76 | $980,288.00 |
DisclosureSEC source: 0001225208-21-011090 · doc4.xml · nonDerivative · entry 1 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 233,051.82 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 26, 2021. Read SEC document |
| August 03, 2021 Filed Jan 29, 2022 00:09 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
GiftCommon Stock | 108,730 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-001132 · doc5.xml · nonDerivative · entry 2 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Living Trust Disclosed balance after: 3,294,017 F1 · balance_after: Reflects the amount owned following this transaction as of August 3, 2021. The total amount owned as of December 31, 2021, which is the Issuer's fiscal year end, is 3,344,017 shares. Read SEC document |
| August 03, 2021 Filed Jan 29, 2022 00:09 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
GiftCommon Stock | 108,730 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-001132 · doc5.xml · nonDerivative · entry 1 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,271.82 Read SEC document |
| August 02, 2021 Filed Aug 3, 2021 01:35 UTC |
Szyman Catherine M.CVP, Critical Care
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 15,000 | $0.00 Strike: $21.76 | $0.00 |
DisclosureSEC source: 0001225208-21-011037 · doc4.xml · derivative · entry 3 Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,882 Underlying: Common Stock · 15,000 shares Expires 2022-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 02, 2021 Filed Aug 3, 2021 01:35 UTC |
Szyman Catherine M.CVP, Critical Care
|
SaleCommon Stock | 15,000 | $113.53 | $1,702,903.50 |
DisclosureSEC source: 0001225208-21-011037 · doc4.xml · nonDerivative · entry 2 Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,758.9088 F1 · price: This transaction was executed in multiple trades at prices ranging from $113.4450 to $113.7500. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 02, 2021 Filed Aug 3, 2021 01:35 UTC |
Szyman Catherine M.CVP, Critical Care
|
Exercise / conversionCommon Stock | 15,000 | $21.76 | $326,400.00 |
DisclosureSEC source: 0001225208-21-011037 · doc4.xml · nonDerivative · entry 1 Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,758.9088 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 12, 2021 Filed Jul 12, 2021 23:37 UTC |
Wood Larry LCVP, TAVR
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 7,830 | $0.00 Strike: $35.20 | $0.00 |
DisclosureSEC source: 0001225208-21-010585 · doc4.xml · derivative · entry 4 Wood Larry L · CIK 0001440660 · CVP, TAVR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,150 Underlying: Common Stock · 7,830 shares Expires 2023-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 12, 2021 Filed Jul 12, 2021 23:37 UTC |
Wood Larry LCVP, TAVR
|
SaleCommon Stock | 7,830 | $107.48 | $841,568.40 |
DisclosureSEC source: 0001225208-21-010585 · doc4.xml · nonDerivative · entry 2 Wood Larry L · CIK 0001440660 · CVP, TAVR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 372,133.5508 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 29, 2021. Read SEC document |
| July 12, 2021 Filed Jul 12, 2021 23:37 UTC |
Wood Larry LCVP, TAVR
|
Exercise / conversionCommon Stock | 7,830 | $35.20 | $275,590.16 |
DisclosureSEC source: 0001225208-21-010585 · doc4.xml · nonDerivative · entry 1 Wood Larry L · CIK 0001440660 · CVP, TAVR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 379,963.5508 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 29, 2021. Read SEC document |
| July 09, 2021 Filed Jul 10, 2021 01:47 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 11,050 | $0.00 Strike: $21.76 | $0.00 |
DisclosureSEC source: 0001225208-21-010551 · doc4.xml · derivative · entry 5 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,450 Underlying: Common Stock · 11,050 shares Expires 2022-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 09, 2021 Filed Jul 10, 2021 01:47 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
SaleCommon Stock | 11,050 | $108.15 | $1,195,110.54 |
DisclosureSEC source: 0001225208-21-010551 · doc4.xml · nonDerivative · entry 2 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,399.3995 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 1, 2021. F2 · price: This transaction was executed in multiple trades at prices ranging from $107.7700 to $108.5500. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 09, 2021 Filed Jul 10, 2021 01:47 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
Exercise / conversionCommon Stock | 11,050 | $21.76 | $240,448.00 |
DisclosureSEC source: 0001225208-21-010551 · doc4.xml · nonDerivative · entry 1 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,449.3995 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 1, 2021. Read SEC document |
| July 08, 2021 Filed Jul 9, 2021 00:18 UTC |
WANG HUIMINCVP, Japan & Intercontinental
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 6,350 | $0.00 Strike: $21.76 | $0.00 |
DisclosureSEC source: 0001225208-21-010518 · doc4.xml · derivative · entry 3 WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,450 Underlying: Common Stock · 6,350 shares Expires 2022-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 08, 2021 Filed Jul 9, 2021 00:18 UTC |
WANG HUIMINCVP, Japan & Intercontinental
|
SaleCommon Stock | 6,350 | $106.72 | $677,672.00 |
DisclosureSEC source: 0001225208-21-010518 · doc4.xml · nonDerivative · entry 2 WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,026.8935 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2021. Read SEC document |
| July 08, 2021 Filed Jul 9, 2021 00:18 UTC |
WANG HUIMINCVP, Japan & Intercontinental
|
Exercise / conversionCommon Stock | 6,350 | $21.76 | $138,176.00 |
DisclosureSEC source: 0001225208-21-010518 · doc4.xml · nonDerivative · entry 1 WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,376.8935 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2021. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 00:25 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 45,050 | $0.00 Strike: $21.76 | $0.00 |
DisclosureSEC source: 0001225208-21-009995 · doc4.xml · derivative · entry 7 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,500 Underlying: Common Stock · 45,050 shares Expires 2022-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 00:25 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
GiftCommon Stock | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-009995 · doc4.xml · nonDerivative · entry 5 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Living Trust Disclosed balance after: 3,172,787 Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 00:25 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
SaleCommon Stock | 16,382 | $104.78 | $1,716,505.96 |
DisclosureSEC source: 0001225208-21-009995 · doc4.xml · nonDerivative · entry 4 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,001.82 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 26, 2021. F3 · price: This transaction was executed in multiple trades at prices ranging from $104.6850 to $104.9700. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 00:25 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
SaleCommon Stock | 16,168 | $104.43 | $1,688,424.24 |
DisclosureSEC source: 0001225208-21-009995 · doc4.xml · nonDerivative · entry 3 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,383.82 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 26, 2021. F2 · price: This transaction was executed in multiple trades at prices ranging from $103.6800 to $104.6800. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 00:25 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
GiftCommon Stock | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-009995 · doc4.xml · nonDerivative · entry 2 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,551.82 Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 00:25 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
Exercise / conversionCommon Stock | 45,050 | $21.76 | $980,288.00 |
DisclosureSEC source: 0001225208-21-009995 · doc4.xml · nonDerivative · entry 1 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 233,051.82 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 26, 2021. Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 00:33 UTC |
Szyman Catherine M.CVP, Critical Care
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 3,410 | $0.00 Strike: $22.29 | $0.00 |
DisclosureSEC source: 0001225208-21-009449 · doc4.xml · derivative · entry 3 Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,410 shares Expires 2022-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 00:33 UTC |
Szyman Catherine M.CVP, Critical Care
|
SaleCommon Stock | 3,410 | $101.17 | $344,989.70 |
DisclosureSEC source: 0001225208-21-009449 · doc4.xml · nonDerivative · entry 2 Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,704.7936 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2020. Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 00:33 UTC |
Szyman Catherine M.CVP, Critical Care
|
Exercise / conversionCommon Stock | 3,410 | $22.29 | $75,997.65 |
DisclosureSEC source: 0001225208-21-009449 · doc4.xml · nonDerivative · entry 1 Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,114.7936 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2020. Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 00:33 UTC |
WANG HUIMINCVP, Japan & Intercontinental
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 6,350 | $0.00 Strike: $21.76 | $0.00 |
DisclosureSEC source: 0001225208-21-009448 · doc4.xml · derivative · entry 3 WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,800 Underlying: Common Stock · 6,350 shares Expires 2022-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 00:33 UTC |
WANG HUIMINCVP, Japan & Intercontinental
|
SaleCommon Stock | 6,350 | $101.00 | $641,369.69 |
DisclosureSEC source: 0001225208-21-009448 · doc4.xml · nonDerivative · entry 2 WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,889.8064 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2021. F2 · price: This transaction was executed in multiple trades at prices ranging from $100.7150 to $101.1900. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 00:33 UTC |
WANG HUIMINCVP, Japan & Intercontinental
|
Exercise / conversionCommon Stock | 6,350 | $21.76 | $138,176.00 |
DisclosureSEC source: 0001225208-21-009448 · doc4.xml · nonDerivative · entry 1 WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,239.8064 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 4, 2021. Read SEC document |
| June 14, 2021 Filed Jun 15, 2021 01:21 UTC |
Wood Larry LCVP, TAVR
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 7,830 | $0.00 Strike: $35.20 | $0.00 |
DisclosureSEC source: 0001225208-21-009386 · doc4.xml · derivative · entry 4 Wood Larry L · CIK 0001440660 · CVP, TAVR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,980 Underlying: Common Stock · 7,830 shares Expires 2023-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 14, 2021 Filed Jun 15, 2021 01:21 UTC |
Wood Larry LCVP, TAVR
|
SaleCommon Stock | 7,830 | $99.91 | $782,295.30 |
DisclosureSEC source: 0001225208-21-009386 · doc4.xml · nonDerivative · entry 2 Wood Larry L · CIK 0001440660 · CVP, TAVR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 372,071.5231 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 29, 2021. Read SEC document |
| June 14, 2021 Filed Jun 15, 2021 01:21 UTC |
Wood Larry LCVP, TAVR
|
Exercise / conversionCommon Stock | 7,830 | $35.20 | $275,590.16 |
DisclosureSEC source: 0001225208-21-009386 · doc4.xml · nonDerivative · entry 1 Wood Larry L · CIK 0001440660 · CVP, TAVR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 379,901.5231 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 29, 2021. Read SEC document |
| June 14, 2021 Filed Jun 15, 2021 01:21 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 11,050 | $0.00 Strike: $21.76 | $0.00 |
DisclosureSEC source: 0001225208-21-009385 · doc4.xml · derivative · entry 5 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,500 Underlying: Common Stock · 11,050 shares Expires 2022-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 14, 2021 Filed Jun 15, 2021 01:21 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
SaleCommon Stock | 11,050 | $99.84 | $1,103,201.06 |
DisclosureSEC source: 0001225208-21-009385 · doc4.xml · nonDerivative · entry 2 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,374.8505 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 1, 2021. F2 · price: This transaction was executed in multiple trades at prices ranging from $99.6300 to $99.9100. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 14, 2021 Filed Jun 15, 2021 01:21 UTC |
BOBO DONALD E JRCVP,Strategy/Corp Development
|
Exercise / conversionCommon Stock | 11,050 | $21.76 | $240,448.00 |
DisclosureSEC source: 0001225208-21-009385 · doc4.xml · nonDerivative · entry 1 BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,424.8505 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 1, 2021. Read SEC document |
| June 14, 2021 Filed Jun 15, 2021 01:21 UTC |
Chopra DaveenCVP, Surgical Structural Heart
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 24,000 | $0.00 Strike: $45.28 | $0.00 |
DisclosureSEC source: 0001225208-21-009384 · doc4.xml · derivative · entry 3 Chopra Daveen · CIK 0001740963 · CVP, Surgical Structural Heart 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,435 Underlying: Common Stock · 24,000 shares Expires 2025-05-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 14, 2021 Filed Jun 15, 2021 01:21 UTC |
Chopra DaveenCVP, Surgical Structural Heart
|
SaleCommon Stock | 24,000 | $99.96 | $2,398,989.60 |
DisclosureSEC source: 0001225208-21-009384 · doc4.xml · nonDerivative · entry 2 Chopra Daveen · CIK 0001740963 · CVP, Surgical Structural Heart 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,827 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2021. F2 · price: This transaction was executed in multiple trades at prices ranging from $99.58 to $100.00. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 14, 2021 Filed Jun 15, 2021 01:21 UTC |
Chopra DaveenCVP, Surgical Structural Heart
|
Exercise / conversionCommon Stock | 24,000 | $45.28 | $1,086,640.80 |
DisclosureSEC source: 0001225208-21-009384 · doc4.xml · nonDerivative · entry 1 Chopra Daveen · CIK 0001740963 · CVP, Surgical Structural Heart 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,827 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2021. Read SEC document |
| June 09, 2021 Filed Jun 10, 2021 00:05 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 45,050 | $0.00 Strike: $21.76 | $0.00 |
DisclosureSEC source: 0001225208-21-009152 · doc4.xml · derivative · entry 6 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 495,550 Underlying: Common Stock · 45,050 shares Expires 2022-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 09, 2021 Filed Jun 10, 2021 00:05 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
GiftCommon Stock | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-009152 · doc4.xml · nonDerivative · entry 4 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Living Trust Disclosed balance after: 3,160,287 Read SEC document |
| June 09, 2021 Filed Jun 10, 2021 00:05 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
SaleCommon Stock | 32,550 | $97.23 | $3,164,836.50 |
DisclosureSEC source: 0001225208-21-009152 · doc4.xml · nonDerivative · entry 3 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,001.82 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 26, 2021. F2 · price: This transaction was executed in multiple trades at prices ranging from $96.8350 to $97.7900. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 09, 2021 Filed Jun 10, 2021 00:05 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
GiftCommon Stock | 12,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-009152 · doc4.xml · nonDerivative · entry 2 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,551.82 Read SEC document |
| June 09, 2021 Filed Jun 10, 2021 00:05 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
Exercise / conversionCommon Stock | 45,050 | $21.76 | $980,288.00 |
DisclosureSEC source: 0001225208-21-009152 · doc4.xml · nonDerivative · entry 1 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 233,051.82 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 26, 2021. Read SEC document |
| May 28, 2021 Filed May 28, 2021 23:38 UTC |
Szyman Catherine M.CVP, Critical Care
|
SaleCommon Stock | 2,061 | $95.29 | $196,392.69 |
DisclosureSEC source: 0001225208-21-008675 · doc4.xml · nonDerivative · entry 1 Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,704.7936 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2020. Read SEC document |
| May 25, 2021 Filed May 25, 2021 23:27 UTC |
Szyman Catherine M.CVP, Critical Care
|
SaleCommon Stock | 4,665.4212 | $96.09 | $448,300.32 |
DisclosureSEC source: 0001225208-21-008560 · doc4.xml · nonDerivative · entry 1 Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,765.7936 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2020. Read SEC document |
| May 24, 2021 Filed May 25, 2021 23:26 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative | 33,000 | $0.00 Strike: $21.76 | $0.00 |
DisclosureSEC source: 0001225208-21-008559 · doc4.xml · derivative · entry 6 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 540,600 Underlying: Common Stock · 33,000 shares Expires 2022-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2021 Filed May 25, 2021 23:26 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
SaleCommon Stock | 26,377 | $95.55 | $2,520,322.35 |
DisclosureSEC source: 0001225208-21-008559 · doc4.xml · nonDerivative · entry 3 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,001.82 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 3, 2020. F3 · price: This transaction was executed in multiple trades at prices ranging from $94.9200 to $95.9200. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 24, 2021 Filed May 25, 2021 23:26 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
SaleCommon Stock | 6,623 | $96.13 | $636,668.99 |
DisclosureSEC source: 0001225208-21-008559 · doc4.xml · nonDerivative · entry 2 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,378.82 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 3, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $95.9400 to $96.4250. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 24, 2021 Filed May 25, 2021 23:26 UTC |
MUSSALLEM MICHAEL ADirector · Chairman & CEO
|
Exercise / conversionCommon Stock | 33,000 | $21.76 | $718,080.00 |
DisclosureSEC source: 0001225208-21-008559 · doc4.xml · nonDerivative · entry 1 MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,001.82 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 3, 2020. Read SEC document |
| May 17, 2021 Filed May 19, 2021 20:31 UTC |
Chopra DaveenCVP, Surgical Structural Heart
|
Tax withholdingCommon Stock | 1,146 | $89.49 | $102,555.54 |
DisclosureSEC source: 0001225208-21-008303 · doc4.xml · nonDerivative · entry 1 Chopra Daveen · CIK 0001740963 · CVP, Surgical Structural Heart 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,827 Read SEC document |
| May 17, 2021 Filed May 19, 2021 20:31 UTC |
Wood Larry LCVP, TAVR
|
Exercise / conversionPerformance Rights · Derivative | 16,406 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-008306 · doc4.xml · derivative · entry 5 Wood Larry L · CIK 0001440660 · CVP, TAVR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,406 shares Expires 2025-05-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On May 17, 2018, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 3, 2021, the Compensation Committee of the Board of Directors determined that 175% of the target number of shares would vest as of May 17, 2021, and the actual number of shares vested are reflected on this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.